Peptide-adjacent price guide
Nicotinamide Mononucleotide
Also known as NMN
Commonly searched applications: NAD+ precursor support, cellular wellness.
Price comparison
Compare Nicotinamide Mononucleotide providers
Select a dose to see the cheapest documented option that covers it. Providers with verified same-price-across-dose terms are included automatically at every applicable dose; there is no separate flat-price selection. Flat-rate and variable dose-tier providers compete together, with verified required fees included. Comparable monthly, 28-day, 30-day, and four-week injection supplies retain their actual billing labels; no monthly equivalent is invented. Unmatched offers remain visible but unranked. Dose tiers are catalog information, not dosing advice.
0 providers
No clinical provider offer is documented for Nicotinamide Mononucleotide yet
Research-use-only and consumer listings remain available in their separate directory when documented.
Regulatory and pricing context
NMN is a nucleotide-derived NAD+ precursor, not a peptide and not NAD+ itself. It is retained only as a peptide-adjacent consumer supplement. Context source
Displayed prices and dose options are provider-stated snapshots. They may vary by dose, formulation, shipping, state, eligibility, insurance, commitment length, and required subscription. “Not listed” means the reviewed public source did not provide a value.
Information only; not medical advice, a safety evaluation, or a provider endorsement.
Research-use-only suppliers are separate. Their catalog prices never enter the prescription-provider comparison above.
View separate research listingsHelp expand the directory
Don’t see a peptide, provider, or supplier you’re interested in?
Email us at contact@PeptideProviderHub.com or visit the contact page for the information to include.